Gsa Capital Partners LLP Idera Pharmaceuticals, Inc. Transaction History

Gsa Capital Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$1.45 - $2.79 $120,937 - $232,699	-83,405 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$2.12 - $3.31 $31,596 - $49,332	-14,904 Reduced 15.16%	83,405 $241,000
Q2 2019 Aug 06, 2019	BUY	$2.37 - $3.97 $77,880 - $130,458	32,861 Added 50.21%	98,309 $262,000
Q1 2019 May 15, 2019	BUY	$2.33 - $3.79 $152,493 - $248,047	65,448 New	65,448 $167,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.